Abstract
Primary aldosteronism (PA) is the most common form of endocrine hypertension. Agonistic autoantibodies against the angiotensin II type 1 receptor (AT1R-Abs) have been described in transplantation medicine and women with pre-eclampsia and more recently in patients with PA. Any functional role of AT1R-Abs in either of the two main subtypes of PA (aldosterone-producing adenoma or bilateral adrenal hyperplasia) requires clarification. In this review, we discuss the studies performed to date on AT1R-Abs in PA.
© Georg Thieme Verlag KG Stuttgart · New York.
MeSH terms
-
Adrenal Cortex Neoplasms / complications
-
Adrenal Cortex Neoplasms / immunology
-
Adrenal Cortex Neoplasms / metabolism
-
Adrenocortical Adenoma / complications
-
Adrenocortical Adenoma / immunology
-
Adrenocortical Adenoma / metabolism
-
Aldosterone / metabolism
-
Angiotensin II Type 1 Receptor Blockers / metabolism
-
Autoantibodies / metabolism
-
Autoantibodies / physiology*
-
Female
-
Humans
-
Hyperaldosteronism / etiology*
-
Hyperaldosteronism / immunology*
-
Hypertension / etiology
-
Hypertension / metabolism
-
Male
-
Pre-Eclampsia / etiology
-
Pre-Eclampsia / metabolism
-
Pregnancy
-
Receptor, Angiotensin, Type 1 / immunology*
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Autoantibodies
-
Receptor, Angiotensin, Type 1
-
Aldosterone